Replication-competent simian immunodeficiency virus (SIV) gag escape mutations archived in latent reservoirs during antiretroviral treatment of SIV-infected macaques

Journal of Virology

Volumn 85, Issue 17, 2011, Pages 9167-9175

  Queen, Suzanne E ^a   Mears, Brian M ^a   Kelly, Kathleen M ^a   Dorsey, Jamie L ^a   Liao, Zhaohao ^a   Dinoso, Jason B ^a   Gama, Lucio ^a   Adams, Robert J ^a   Zink, M Christine ^a   Clements, Janice E ^a   Kent, Stephen J ^b   Mankowski, Joseph L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ATAZANAVIR; INTEGRASE INHIBITOR; L 870812; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SAQUINAVIR; TENOFOVIR; UNCLASSIFIED DRUG; VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISEASE CARRIER; LYMPHOCYTE; MACACA; MUTATIONAL ANALYSIS; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PLASMA; PRIMATE DISEASE; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN IMMUNODEFICIENCY VIRUS INFECTION; STRUCTURAL GENE; TREATMENT INDICATION; VIREMIA; VIRUS INFECTION; VIRUS INHIBITION; VIRUS REPLICATION;

AMINO ACID SUBSTITUTION; ANIMALS; ANTI-RETROVIRAL AGENTS; CD8-POSITIVE T-LYMPHOCYTES; GENE PRODUCTS, GAG; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNODOMINANT EPITOPES; MACACA; MUTATION, MISSENSE; SELECTION, GENETIC; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; MACACA; REPLICATION COMPETENT VIRUSES; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 80052286937     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00366-11     Document Type: Article

References (39)

1. Babas, T., et al. 2003. Role of microglial cells in selective replication of simian immunodeficiency virus genotypes in the brain. J. Virol. 77:208-216.
2. Bailey, J. R., et al. 2006. Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4 T cells. J. Virol. 80:6441-6457.
3. Bailey, J. R., T. M. Williams, R. F. Siliciano, and J. N. Blankson. 2006. Maintenance of viral suppression in HIV-1-infected HLA-B*57 elite suppressors despite CTL escape mutations. J. Exp. Med. 203:1357-1369.
4. Borrow, P., H. Lewicki, B. H. Hahn, G. M. Shaw, and M. B. Oldstone. 1994. Virus-specific CD8 cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
5. Carrington, M., and S. J. O'Brien. 2003. The influence of HLA genotype on AIDS. Annu. Rev. Med. 54:535-551.
6. Chun, T. W., et al. 1997. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. U. S. A. 94:13193-13197.
7. Cline, A. N., J. W. Bess, M. Piatak, Jr., and J. D. Lifson. 2005. Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS. J. Med. Primatol. 34:303-312.
8. Dalmasso, C., et al. 2008. Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 study. PLoS One 3:e3907.
9. Dinoso, J. B., et al. 2009. A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy. J. Virol. 83:9247-9257.
10. Fellay, J., et al. 2009. Common genetic variation and the control of HIV-1 in humans. PLoS Genet. 5:e1000791.
11. Fellay, J., et al. 2007. A whole-genome association study of major determinants for host control of HIV-1. Science 317:944-947.
12. Fernandez, C. S., et al. 2005. Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost. J. Virol. 79:5721-5731.
13. Finzi, D., et al. 1999. Latent infection of CD4 T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 5:512-517.
14. Finzi, D., et al. 1997. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:1295-1300.
15. Goepfert, P. A., et al. 2008. Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients. J. Exp. Med. 205:1009-1017.
16. Goulder, P. J., and D. I. Watkins. 2008. Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat. Rev. Immunol. 8:619-630.
17. Herbeck, J. T., et al. 2010. Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS. J. Infect. Dis. 201:618-626.
18. Kawashima, Y., et al. 2009. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 458:641-645.
19. Kosmrlj, A., et al. 2010. Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection. Nature 465:350-354.
20. Le Clerc, S., et al. 2009. Genomewide association study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRS Genomewide Association Study 03). J. Infect. Dis. 200:1194-1201.
21. Letendre, S., et al. 2008. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch. Neurol. 65:65-70.
22. Limou, S., et al. 2009. Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J. Infect. Dis. 199:419-426.
23. Loh, L., et al. 2009. Complexity of the inoculum determines the rate of reversion of SIV Gag CD8 T cell mutant virus and outcome of infection. PLoS Pathog. 5:e1000378.
24. Mankowski, J. L., et al. 2008. Natural host genetic resistance to lentiviral CNS disease: a neuroprotective MHC class I allele in SIV-infected macaques. PLoS One 3:e3603.
25. Migueles, S. A., et al. 2000. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc. Natl. Acad. Sci. U. S. A. 97:2709-2714.
26. Moore, C. B., et al. 2002. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296:1439-1443.
27. O'Leary, C. E., et al. 2009. Identification of novel MHC class I sequences in pig-tailed macaques by amplicon pyrosequencing and full-length cDNA cloning and sequencing. Immunogenetics 61:689-701.
28. Pelak, K., et al. 2010. Host determinants of HIV-1 control in African Americans. J. Infect. Dis. 201:1141-1149.
29. Pereyra, F., et al. 2010. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330:1551-1557.
30. Shen, A., et al. 2007. Novel pathway for induction of latent virus from resting CD4(+) T cells in the simian immunodeficiency virus/macaque model of human immunodeficiency virus type 1 latency. J. Virol. 81:1660-1670.
31. Shen, A., et al. 2003. Resting CD4 T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy. J. Virol. 77:4938-4949.
32. Siliciano, J. D., et al. 2003. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4 T cells. Nat. Med. 9:727-728.
33. Smith, M. Z., et al. 2008. Limited maintenance of vaccine-induced simian immunodeficiency virus-specific CD8 T-cell receptor clonotypes after virus challenge. J. Virol. 82:7357-7368.
34. Smith, M. Z., et al. 2005. The pigtail macaque MHC class I allele Mane-A*10 presents an immundominant SIV Gag epitope: identification, tetramer development and implications of immune escape and reversion. J. Med. Primatol. 34:282-293.
35. Steers, N. J., et al. 2011. Cell type-specific proteasomal processing of HIV-1 Gag-p24 results in an altered epitope repertoire. J. Virol. 85:1541-1553.
36. Witwer, K. W., et al. 2009. Coordinated regulation of SIV replication and immune responses in the CNS. PLoS One 4:e8129.
37. Wong, J. K., et al. 1997. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278:1291-1295.
38. Zink, M. C., et al. 1997. Pathogenesis of SIV encephalitis. Selection and replication of neurovirulent SIV. Am. J. Pathol. 151:793-803.
39. Zink, M. C., et al. 2010. Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA. J. Infect. Dis. 202:161-170.